- Erscheinungsweise vierteljährlich
- ca. 70 Seiten
- ISSN 2751-3971
- eISSN 2751-398X
- Sprache: Englisch
EHPL – European Health & Pharmaceutical Law Review
EHPL 4/2025 Out Now
The fourth issue of the European Health & Pharmaceutical Law Review (EHPL) for 2025 is now available! This edition features:
Editorial by Teodora Lalova-Spinks
Opinions:
The WHO Pandemic Agreement and the EU Legal Order in Times of Global Health Crises by Claudia Seitz
Public Empowerment Within the Framework of the EHDS: Citizens Show Why Opting Out Is Not the Silver Bullet by Marlies Saelaert, Wannes Van Hoof
Articles:
Clearly Defining Responsibilities and Practical Solutions to Empower Data Subjects in the EHDS: Do Health Data Access Bodies Come to the Rescue? by Michiel Fierens
The Opt-Out Mechanism from Secondary Use in the European Health Data Space (EHDS) Regulation: Catalyst or Barrier to Patient Engagement? by Antonios Roussos
This issue also includes the following reports:
AI in Healthcare as a Lens on Regulatory and Governance Culture: Europe vs. Australia by Tobias J. Schulz
Patentability of AI-based Inventions in the Pharmaceutical Field Under the European Patent Law by Paolo Di Giovine
Sie möchten einen Beitrag einreichen oder zur Weiterentwicklung der EHPL beitragen? Dann nutzen Sie unseren Call for Papers (englischsprachig). Weitere Details zur EHPL finden Sie auf der englischsprachigen Website.